论文部分内容阅读
中医药的悠久历史及其对人类的巨大供献,对东方民族的繁衍昌盛所起到的作用,是举世共睹的。但这一历史文化到了西方特别是美国,却会遇到不少困难。不过,最近这一极难通过的关口却被一位美籍华人,现年62岁的生化学家、美国“康乃狄克老化与癌症研究所”医学主任——孙士铣教授冲开。他经过近10年的研究,以19种再普通不过的草本植物、中药等所制成的复方中药——华阳复方,一举通过了向来以严格出名的美国食品及药物管理局(FDA)第一、二期试验,证明对肺癌有
The long history of Chinese medicine and its tremendous contribution to mankind have played a role in the prosperity and prosperity of the Oriental nation. However, this historical culture has reached the West, especially the United States, but it will encounter many difficulties. However, this extremely difficult pass has recently been crossed by a Chinese-American, a 62-year-old biochemist, and Sun Shi-Chan, the medical director of the Connecticut Institute for Aging and Cancer. After nearly 10 years of research, Huayang Compound, a compound traditional Chinese medicine made from 19 kinds of common herbs and Chinese medicines, has passed the US Food and Drug Administration (FDA), which has always been known to the United States. Phase I and II trials prove that there is lung cancer